「DIFF+」is DIFF Biotech's CRO service platform. The ultimate goal of recombinant viral vector technology is to transform cutting-edge life science technologies into productive solutions for existing industry challenges. Currently,「DIFF+」can facilitate technology conversion and empowerment across multiple fields, including antiviral drug development, oncolytic virus development, gene therapy, and novel vaccine development. It represents a significant opportunity to expand the technological boundaries of DIFF Biotech